Novigenix, a leader in AI-driven healthcare solutions, has published a groundbreaking study showcasing the predictive power of its LITOSeek™ platform for immunotherapy response in metastatic urothelial cancer.
The value of CNS-specific eCOA provider in clinical trials – Pharmaceutical Technology
CNS assessments should be a consideration for all clinical trials, not just those that are CNS-based. Credit: ESB Professional via Shutterstock. The pharmaceutical industry is